178 related articles for article (PubMed ID: 1696248)
21. Evaluation of pentisomide on stable ventricular premature beats. Comparison with placebo.
Mangini SG; Mastropasqua F; Oldani V; Massari F; Maino GN; Ricci A; Scrutinio D; Rizzon P
Eur Heart J; 1991 Jun; 12(6):712-9. PubMed ID: 1713557
[TBL] [Abstract][Full Text] [Related]
22. [Estimation of the long-term efficacy of anti-arrhythmia treatment with flecainide in ventricular tachycardia].
Fauchier JP; Cosnay P; Babuty B; Moquet B; Rouesnel P; Estepo J
Arch Mal Coeur Vaiss; 1990 Jan; 83(1):77-83. PubMed ID: 2106308
[TBL] [Abstract][Full Text] [Related]
23. [Comparative study of the anti-arrhythmia effect of flecainide acetate and prajmalium bitartrate in patients with tachycardiac ventricular rhythm disorders].
Andresen D; von Leitner ER; Wegscheider K; Theiss A; Agena H; Schröder R
Z Kardiol; 1986 Jul; 75(7):394-401. PubMed ID: 2429466
[TBL] [Abstract][Full Text] [Related]
24. [Short- and medium-term treatment of ventricular hyperkinetic arrhythmia with flecainide].
Gallicchio F; Aragona PL; Chiatto M; Pugliese F; Donnangelo L
Clin Ter; 1989 May; 129(3):173-84. PubMed ID: 2527112
[TBL] [Abstract][Full Text] [Related]
25. [Electrophysiological changes of the excitoconduction system in patients with Chagas cardiomyopathy and their modification by flecainide].
Abitbol HF; Carrizo Paez R; Derlis Abate C
Arch Inst Cardiol Mex; 1988; 58(2):107-14. PubMed ID: 2456750
[TBL] [Abstract][Full Text] [Related]
26. [Study of flecainide in the treatment of ventricular arrhythmia].
Hug C; Koliopoulos N; Tardy C; Errera J; Puech P
Ann Cardiol Angeiol (Paris); 1983 May; 32(3):161-4. PubMed ID: 6193751
[TBL] [Abstract][Full Text] [Related]
27. [Long-term therapy with flecainide].
Bramann HU; Bender F; Jachmann H; Grosse-Heitmeyer W
Z Kardiol; 1984 Nov; 73(11):724-31. PubMed ID: 6084367
[TBL] [Abstract][Full Text] [Related]
28. [Antiarrhythmic efficacy of mexiletine, propafenone and flecainide in ventricular premature beats. A comparative study in patients after myocardial infarction (author's transl)].
Klempt HW; Nayebagha A; Fabry E
Z Kardiol; 1982 May; 71(5):340-9. PubMed ID: 6180562
[TBL] [Abstract][Full Text] [Related]
29. [Diprafenone--comparative study of anti-arrhythmia therapy with propafenone].
Geibel A; Zehender M; Hohnloser S; Landsrath C; Meinertz T; Just H
Z Kardiol; 1988 Jul; 77(7):464-9. PubMed ID: 2463720
[TBL] [Abstract][Full Text] [Related]
30. High dose caffeine and ventricular arrhythmias.
Myers MG; Harris L
Can J Cardiol; 1990 Apr; 6(3):95-8. PubMed ID: 1692755
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of flecainide for ventricular arrhythmias in patients with Andersen-Tawil syndrome with KCNJ2 mutations.
Miyamoto K; Aiba T; Kimura H; Hayashi H; Ohno S; Yasuoka C; Tanioka Y; Tsuchiya T; Yoshida Y; Hayashi H; Tsuboi I; Nakajima I; Ishibashi K; Okamura H; Noda T; Ishihara M; Anzai T; Yasuda S; Miyamoto Y; Kamakura S; Kusano K; Ogawa H; Horie M; Shimizu W
Heart Rhythm; 2015 Mar; 12(3):596-603. PubMed ID: 25496985
[TBL] [Abstract][Full Text] [Related]
32. Suppression of complex ventricular arrhythmias by oral flecainide.
Duran D; Platia EV; Griffith LS; Adhar G; Reid PR
Clin Pharmacol Ther; 1982 Nov; 32(5):554-61. PubMed ID: 7127996
[TBL] [Abstract][Full Text] [Related]
33. Antiarrhythmic treatment with flecainide (Tambocor). Clinical experience from 107 patients.
Frandsen F; Pless P; Mickley H; Møller M
Acta Cardiol; 1990; 45(5):351-7. PubMed ID: 1704167
[TBL] [Abstract][Full Text] [Related]
34. Flecainide: one-year efficacy in patients with chronic ventricular arrhythmias.
Vanhaleweyk G; Balakumaran K; Lubsen J; ten Cate FJ; Jovanovic A; Hagemeijer F; Withagen A; Polak BC; Roelandt J; Hugenholtz PG
Eur Heart J; 1984 Oct; 5(10):814-23. PubMed ID: 6499854
[TBL] [Abstract][Full Text] [Related]
35. Sinusoidal ventricular tachycardia associated with flecainide acetate.
Sellers TD; DiMarco JP
Chest; 1984 May; 85(5):647-9. PubMed ID: 6201323
[TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of oral flecainide acetate in patients with cardiac arrhythmias.
Nakazato Y; Nakata Y; Yasuda M; Nakazato K; Sumiyoshi M; Ogura S; Yamaguchi H
Jpn Heart J; 1997 May; 38(3):379-85. PubMed ID: 9290572
[TBL] [Abstract][Full Text] [Related]
37. Flecainide versus quinidine for treatment of chronic ventricular arrhythmias. A multicenter clinical trial.
Circulation; 1983 May; 67(5):1117-23. PubMed ID: 6339110
[TBL] [Abstract][Full Text] [Related]
38. Flecainide: steady state electrophysiologic effects in patients with remote myocardial infarction and inducible sustained ventricular arrhythmia.
Webb CR; Morganroth J; Senior S; Spielman SR; Greenspan AM; Horowitz LN
J Am Coll Cardiol; 1986 Jul; 8(1):214-20. PubMed ID: 3711519
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of flecainide in low-risk patients with chronic ventricular arrhythmias: a two-year follow-up.
Facchini M; Varisco T; Bonazzi O; Priori SG; Songa V; Schwartz PJ
Am Heart J; 1989 Jun; 117(6):1258-64. PubMed ID: 2499170
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the efficacy of flecainide acetate in the treatment of ventricular premature contractions.
Muhiddin KA; Turner P; Hellestrand K; Camm AJ
Postgrad Med J; 1985 Jun; 61(716):489-96. PubMed ID: 2409543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
